(Q37841383)

English

Performance of the aspartate aminotransferase-to-platelet ratio index for the staging of hepatitis C-related fibrosis: an updated meta-analysis

scientific article published on 11 February 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

0 references

1 reference

Europe PubMed Central

Performance of the aspartate aminotransferase-to-platelet ratio index for the staging of hepatitis C-related fibrosis: an updated meta-analysis (English)

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

0 references

author name string

Zhong-Hua Lin

1

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

Yong-Ning Xin

2

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

Quan-Jiang Dong

3

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

Qing Wang

4

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

Xiang-Jun Jiang

5

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

Shu-Hui Zhan

6

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

Ying Sun

7

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

Shi-Ying Xuan

8

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

language of work or name

0 references

publication date

11 February 2011

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

53

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

726-736

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

Hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24105

21 January 2018

Natural history of compensated viral cirrhosis: a prospective study on the incidence and hierarchy of major complications

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24105

21 January 2018

Clinical guidelines on the management of hepatitis C

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24105

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24105

21 January 2018

A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24105

21 January 2018

Diagnostic accuracy of the aspartate aminotransferase-to-platelet ratio index for the prediction of hepatitis C-related fibrosis: a systematic review

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24105

21 January 2018

Conducting systematic reviews of diagnostic studies: didactic guidelines

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24105

21 January 2018

The development of QUADAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24105

21 January 2018

Classification of chronic viral hepatitis: a need for reassessment

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24105

21 January 2018

Histological grading and staging of chronic hepatitis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24105

21 January 2018

Diagnosis, management, and treatment of hepatitis C

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24105

21 January 2018

Meta-DiSc: a software for meta-analysis of test accuracy data.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24105

21 January 2018

A systematic review of the diagnostic accuracy of natriuretic peptides for heart failure

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24105

21 January 2018

Measuring inconsistency in meta-analyses

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24105

21 January 2018

The performance of tests of publication bias and other sample size effects in systematic reviews of diagnostic test accuracy was assessed.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24105

21 January 2018

Comparison of liver fibrosis blood tests developed for HCV with new specific tests in HIV/HCV co-infection

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24105

21 January 2018

Improved diagnostic accuracy of blood tests for severe fibrosis and cirrhosis in chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24105

21 January 2018

Early detection in routine clinical practice of cirrhosis and oesophageal varices in chronic hepatitis C: comparison of transient elastography (FibroScan) with standard laboratory tests and non-invasive scores

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24105

21 January 2018

Prediction of significant liver fibrosis in kidney transplant patients with chronic hepatitis C virus infection: the TX-3 index.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24105

21 January 2018

Accuracy of simple biochemical tests in identifying liver fibrosis in patients co-infected with human immunodeficiency virus and hepatitis C virus

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24105

21 January 2018

Optimized cutoffs improve performance of the aspartate aminotransferase to platelet ratio index for predicting significant liver fibrosis in human immunodeficiency virus/hepatitis C virus co-infection

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24105

21 January 2018

Can we predict the degree of fibrosis in chronic hepatitis C patients using routine blood tests in our daily practice?

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24105

21 January 2018

13C-methacetin-breath test compared to also noninvasive biochemical blood tests in predicting hepatic fibrosis and cirrhosis in chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24105

21 January 2018

Validation and comparison of simple noninvasive indexes for predicting liver fibrosis in HIV-HCV-coinfected patients: ANRS CO3 Aquitaine cohort

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24105

21 January 2018

A non-invasive algorithm accurately predicts advanced fibrosis in hepatitis C: a comparison using histology with internal-external validation

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24105

21 January 2018

Serum levels of YKL-40 and hyaluronic acid as noninvasive markers of liver fibrosis in haemodialysis patients with chronic hepatitis C virus infection.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24105

21 January 2018

Comparison of test performance profile for blood tests of liver fibrosis in chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24105

21 January 2018

Prospective comparison of six non-invasive scores for the diagnosis of liver fibrosis in chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24105

21 January 2018

Simple blood tests as noninvasive markers of liver fibrosis in hemodialysis patients with chronic hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24105

21 January 2018

Role of AST to platelet ratio index in the detection of liver fibrosis in patients with recurrent hepatitis C after liver transplantation

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24105

21 January 2018

Validation and comparison of indexes for fibrosis and cirrhosis prediction in chronic hepatitis C patients: proposal for a pragmatic approach classification without liver biopsies

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24105

21 January 2018

Aspartate aminotransferase to platelet ratio index for fibrosis evaluation in chronic viral hepatitis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24105

21 January 2018

Assessment of liver fibrosis progression in patients with chronic hepatitis C and normal alanine aminotransferase values: the role of AST to the platelet ratio index.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24105

21 January 2018

Noninvasive tests for the prediction of significant hepatic fibrosis in hepatitis C virus carriers with persistently normal alanine aminotransferases.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24105

21 January 2018

Prediction of liver fibrosis in human immunodeficiency virus/hepatitis C virus coinfected patients by simple non-invasive indexes

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24105

21 January 2018

Noninvasive serum markers in the diagnosis of structural liver damage in chronic hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24105

21 January 2018

Patient age is a strong independent predictor of 13C-aminopyrine breath test results: a comparative study with histology, duplex-Doppler and a laboratory index in patients with chronic hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24105

21 January 2018

Progression of liver fibrosis among injection drug users with chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24105

21 January 2018

Validation of a simple model for predicting liver fibrosis in HIV/hepatitis C virus-coinfected patients.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24105

21 January 2018

Cirrhosis in hepatitis C virus-infected patients can be excluded using an index of standard biochemical serum markers

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24105

21 January 2018

Prediction of hepatic fibrosis in HIV/HCV co-infected patients using serum fibrosis markers: the SHASTA index

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24105

21 January 2018

Comparison and validation of simple noninvasive tests for prediction of fibrosis in chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24105

21 January 2018

HIV infection does not affect the performance of noninvasive markers of fibrosis for the diagnosis of hepatitis C virus-related liver disease

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24105

21 January 2018

Does noninvasive staging of fibrosis challenge liver biopsy as a gold standard in chronic hepatitis C?

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24105

21 January 2018

HIV-related thrombocytopenia

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24105

21 January 2018

FibroTest and FibroScan for the prediction of hepatitis C-related fibrosis: a systematic review of diagnostic test accuracy

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24105

21 January 2018

Aspartate aminotransferase to platelet ratio index (APRI) can predict liver fibrosis in chronic hepatitis B.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24105

21 January 2018

Noninvasive laboratory tests proposed for predicting cirrhosis in patients with chronic hepatitis C are also useful in patients with non-alcoholic steatohepatitis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24105

21 January 2018

Comparison of noninvasive markers of fibrosis in patients with nonalcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24105

21 January 2018

Assessment of liver fibrosis in transplant recipients with recurrent HCV infection: usefulness of transient elastography

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24105

21 January 2018

Biological markers of liver fibrosis and activity as non-invasive alternatives to liver biopsy in patients with chronic hepatitis C and associated mixed cryoglobulinemia vasculitis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24105

21 January 2018

Burden of liver disease in the United States: summary of a workshop

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24105

7 January 2021

based on heuristic

inferred from DOI database lookup

Chronic hepatitis. An update on terminology and reporting.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24105

7 January 2021

based on heuristic

inferred from DOI database lookup

Non-invasive markers of hepatic fibrosis in patients co-infected with HCV and HIV: comparison of the APRI and FIB-4 index

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24105

7 January 2021

based on heuristic

inferred from DOI database lookup

Aspartate aminotransferase to platelet ratio index in patients with alcoholic liver fibrosis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24105

7 January 2021

based on heuristic

inferred from DOI database lookup

Insulin resistance as a non-invasive method for the assessment of fibrosis in patients with hepatitis C: a comparative study of biochemical methods

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24105

7 January 2021

based on heuristic

inferred from DOI database lookup

APRI: an easy and validated predictor of hepatic fibrosis in chronic hepatitis C

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24105

7 January 2021

based on heuristic

inferred from DOI database lookup

Noninvasive ratio indexes to evaluate fibrosis staging in chronic hepatitis C: role of platelet count/spleen diameter ratio index

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24105

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/HEP.24105

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37841383&oldid=2102073936"